Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Max Mek
Nov 19, 2021 10:13AM ET
BEST BEAR PROMOTION!!!
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⏰ React to the Market Faster with Custom, Real-Time News Get Started
1.90
-0.16
-7.75%
After Hours
1.92
+0.02
+0.79%
19:59:51 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 4,101,130
- Bid/Ask: 0.00 / 0.00
- Day's Range: 1.80 - 2.20
Heron Therapeuti
1.90
-0.16
-7.75%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
HRTX Income Statement
Featured here, the Income Statement (earnings report) for Heron Therapeuti, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
| Period Ending: | 2022 31/12 |
2022 30/09 |
2022 30/06 |
2022 31/03 |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 30.03 | 26.56 | 27.63 | 23.46 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Cost of Revenue, Total | 23.68 | 40.26 | 45.01 | 53.42 | ||||||||||||||||||||||||||||||
| Gross Profit | 6.34 | -13.7 | -17.38 | -29.97 | ||||||||||||||||||||||||||||||
| Total Operating Expenses | 50.38 | 68.44 | 77.13 | 86.38 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Operating Income | -20.36 | -41.88 | -49.5 | -62.92 | ||||||||||||||||||||||||||||||
| Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
| Gain (Loss) on Sale of Assets | - | - | - | -0.096 | ||||||||||||||||||||||||||||||
| Other, Net | -0.486 | 0.026 | 6.86 | 1.06 | ||||||||||||||||||||||||||||||
| Net Income Before Taxes | -19.87 | -41.91 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Provision for Income Taxes | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income After Taxes | -19.87 | -41.91 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
| Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
| U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income Before Extraordinary Items | -19.87 | -41.91 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income | -19.87 | -41.91 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
| Income Available to Common Excluding Extraordinary Items | -19.87 | -41.91 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Dilution Adjustment | - | 0.551 | - | - | ||||||||||||||||||||||||||||||
| Diluted Net Income | -19.87 | -42.46 | -56.36 | -63.89 | ||||||||||||||||||||||||||||||
| Diluted Weighted Average Shares | 116.88 | 111.74 | 102.4 | 102.12 | ||||||||||||||||||||||||||||||
| Diluted EPS Excluding Extraordinary Items | -0.17 | -0.38 | -0.55 | -0.626 | ||||||||||||||||||||||||||||||
| DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Normalized EPS | -0.106 | -0.234 | -0.344 | -0.39 | ||||||||||||||||||||||||||||||
* In Millions of USD (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Heron Therapeuti
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Алексей Морма
May 13, 2021 1:41PM ET
!!!! Heron's stock rises after FDA approval of surgical medicine
1
0
Joe Jordan
Feb 20, 2021 2:09AM ET
Can this go back to 30 dollars?
1
0
PeterM
Jan 08, 2018 5:18PM ET
Strong squeeze play candidate with prices consolidating and a recent pocket pivot. A lot of large players seem to be buying in. #Bullish
1
0
oguzhan ozturk
Jan 08, 2018 5:18PM ET
Target price seems 32$ in 12 months? Do you agree?
2
0
Joel Hanson
Nov 28, 2016 4:32PM ET
$HRTX has all 9 analyst saying “BUY” with an ave 12 month target price of $37.33 which is 144% ROI at is closing price of $15.28
2
1
oguzhan ozturk
Nov 28, 2016 4:32PM ET
Still sluggish
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review